The rising popularity of “weight loss pens” has created a notable buzz worldwide, including here in the United States.These medications, initially developed for managing type 2 diabetes and severe obesity, are now frequently sought after for their weight-reducing effects. As of January 12, 2026, the demand continues to surge, prompting a closer look at their use, impact, and the surrounding controversies.
Initially prescribed under strict medical guidance, these drugs are increasingly being adopted without proper pharmaceutical oversight, solely for weight loss purposes. Recent research, including a study published in Obesity, has sought